Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy

Nutrition and Cancer

Volumn 67, Issue 8, 2015, Pages 1223-1231

  González Vallinas, Margarita ^a,c   Reglero, Guillermo ^b   Ramírez De Molina, Ana ^a  

^a IMDEA FOOD INSTITUTE   (Spain)

^b CSIC   (Spain)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZIDOPINE; CARNOSIC ACID; CARNOSOL; CISPLATIN; DOXORUBICIN; FLUOROURACIL; PACLITAXEL; ROSMARINIC ACID; ROSMARINUS OFFICINALIS EXTRACT; TAMOXIFEN; TRASTUZUMAB; URSOLIC ACID; VINBLASTINE; ABIETANE DERIVATIVE; ANTIOXIDANT; CINNAMIC ACID DERIVATIVE; DEPSIDE; PLANT EXTRACT; TRITERPENE;

ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CACO 2 CELL LINE; CANCER INHIBITION; CANCER RESISTANCE; CANCER THERAPY; COLON CANCER; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENDOPLASMIC RETICULUM STRESS; HUMAN; IMMUNOMODULATION; LEUKEMIA; LIVER CANCER; LUNG CANCER; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SKIN CANCER; UTERINE CERVIX CANCER; BREAST NEOPLASMS; CHEMISTRY; DRUG INTERACTION; EUROPE; FOOD AND DRUG ADMINISTRATION; NEOPLASMS; PHYTOTHERAPY; ROSMARINUS; UNITED STATES;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; BREAST NEOPLASMS; CINNAMATES; DEPSIDES; DITERPENES, ABIETANE; DRUG INTERACTIONS; EUROPE; HUMANS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; ROSMARINUS; TRITERPENES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84948699907     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1082110     Document Type: Review

References (53)

1. Kim HK, Wilson EG, Choi YH, and Verpoorte R: Metabolomics: a tool for anticancer lead-finding from natural products. Planta Med 76, 1094-1102, 2010. doi:10.1055/s-0030-1249898
2. Aggarwal BB and Kunnumakkara AB: Molecular Targets and Therapeutic Uses of Spices: Modern Uses for Ancient Medicine: Singapore, World Scientific Publishing Group, 2009.
3. Ulbricht C, Abrams TR, Brigham A, Ceurvels J, Clubb J, et al.: An evidence-based systematic review of rosemary (Rosmarinus officinalis) by the Natural Standard Research Collaboration. J Diet Suppl 7, 351-413, 2010. doi:10.3109/19390211.2010.525049
4. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100, 57-70, 2000.
5. Cheung S and Tai J: Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol Rep 17, 1525-1531, 2007.
6. Yesil-Celiktas O, Sevimli C, Bedir E, and Vardar-Sukan F: Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum Nutr 65, 158-163, 2010. doi:10.1007/s11130-010-0166-4
7. Mothana RA, Kriegisch S, Harms M, Wende K, and Lindequist U: Assessment of selected Yemeni medicinal plants for their in vitro antimicrobial, anticancer, and antioxidant activities. Pharm Biol 49, 200-210, 2011. doi:10.3109/13880209.2010.512295
8. ilas S, Knez -Z, -Cetojevic-Simin D, Tumbas V, -Skerget M, et al.: In vitro antioxidant and antiproliferative activity of three rosemary (Rosmarinus officinalis L.) extract formulations. International Journal of Food Science & Technology 47, 2052-2062, 2012.
9. Gonzalez-Vallinas M, Molina S, Vicente G, Sanchez-Martnez R, Vargas T, et al.: Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells. Electrophoresis 35, 1719-1727, 2014. doi: 10.1002/elps.201400011
10. Valdes A, Garca-Canas V, Rocamora-Reverte L, Gomez-Martnez A, Ferragut JA, et al.: Effect of rosemary polyphenols on human colon cancer cells: transcriptomic profiling and functional enrichment analysis. Genes Nutr 8, 43-60, 2013. doi:10.1007/s12263-012-0311-9
11. Peng CH, Su JD, Chyau CC, Sung TY, Ho SS, et al.: Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and antitumor effects. Biosci Biotechnol Biochem 71, 2223-2232, 2007.
12. Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, et al.: Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 54, 701-708, 1994.
13. Singletary K, MacDonald C, and Wallig M: Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett 104, 43-48, 1996.
14. Singletary KW: Rosemary extract and carnosol stimulate rat liver glutathione-S-transferase and quinone reductase activities. Cancer Lett 100, 139-144, 1996.
15. Singletary KW and Rokusek JT: Tissue-specific enhancement of xenobiotic detoxification enzymes in mice by dietary rosemary extract. Plant Foods Hum Nutr 50, 47-53, 1997.
16. Slamenova D, Kuboskova K, Horvathova E, and Robichova S: Rosemarystimulated reduction of DNA strand breaks and FPG-sensitive sites in mammalian cells treated with H2O2 or visible light-excited Methylene Blue. Cancer Lett 177, 145-153, 2002.
17. Zhu BT, Loder DP, Cai MX, Ho CT, Huang MT, et al.: Dietary administration of an extract from rosemary leaves enhances the liver microsomal metabolism of endogenous estrogens and decreases their uterotropic action in CD-1 mice. Carcinogenesis 19, 1821-1827, 1998.
18. Yi W and Wetzstein HY: Anti-tumorigenic activity of five culinary and medicinal herbs grown under greenhouse conditions and their combination effects. J Sci Food Agric 91, 1849-1854, 2011. doi:10.1002/jsfa.4394
19. Ibanez C, Simo C, Garca-Canas V, Gomez-Martnez A, Ferragut JA, et al.: CE/LC-MS multiplatform for broad metabolomic analysis of dietary polyphenols effect on colon cancer cells proliferation. Electrophoresis 33, 2328-2336, 2012. doi:10.1002/elps.201200143
20. Berrington D and Lall N: Anticancer activity of certain herbs and spices on the cervical epithelial carcinoma (HeLa) cell line. Evid Based Complement Alternat Med 2012, 564927, 2012. doi:10.1155/2012/564927
21. Tai J, Cheung S, Wu M, and Hasman D: Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. Phytomedicine 19, 436-443, 2012. doi:10.1016/j.phymed.2011.12.012
22. Gonzalez-Vallinas M, Molina S, Vicente G, Zarza V, Martn-Hernandez R, et al.: Expression of MicroRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of rosemary diterpenes in colon and pancreatic cancer. PLoS One 9, e98556, 2014. doi:10.1371/journal.pone.0098556
23. Petiwala SM, Berhe S, Li G, Puthenveetil AG, Rahman O, et al.: Rosemary (Rosmarinus officinalis) extract modulates CHOP/GADD153 to promote androgen receptor degradation and decreases xenograft tumor growth. PLoS One 9, e89772, 2014. doi:10.1371/journal.pone.0089772
24. Gonzalez-Vallinas M, Molina S, Vicente G, de la Cueva A, Vargas T, et al.: Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol Res 72, 61-68, 2013. doi:10.1016/j.phrs.2013.03.010
25. Wang W, Li N, Luo M, Zu Y, and Efferth T: Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules 17, 2704-2713, 2012. doi:10.3390/molecules17032704
26. Vicente G, Molina S, Gonzalez-Vallinas M, Garca-Risco MR, Fornari T, et al.: Supercritical rosemary extracts, their antioxidant activity and effect on hepatic tumor progression. The Journal of Supercritical Fluids 79, 101-108, 2013. doi:http://dx.doi.org/10.1016/j.supflu.2012.07.006
27. Kontogianni VG, Tomic G, Nikolic I, Nerantzaki AA, Sayyad N, et al.: Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity. Food Chem 136, 120-129, 2013. doi:10.1016/j.foodchem.2012.07.091
28. Sancheti G and Goyal PK: Effect of Rosmarinus officinalis in modulating 7,12-dimethylbenz(a)anthracene induced skin tumorigenesis in mice. Phytother Res 20, 981-986, 2006. doi:10.1002/ptr.1989
29. Petiwala SM, Puthenveetil AG, Johnson JJ: Polyphenols from the Mediterranean herb rosemary (Rosmarinus officinalis) for prostate cancer. Front Pharmacol 4, 29, 2013. doi:10.3389/fphar.2013.00029
30. Ahmad HH, Hamza AH, Hassan AZ, and Sayed AH: Promising therapeutic role of Rosmarinus officinalis successive methanolic fraction against colorectal cancer. International Journal of Pharmacy and Pharmaceutical Sciences 5, 164-170, 2013.
31. Einbond LS, Wu HA, Kashiwazaki R, He K, Roller M, et al.: Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin. Fitoterapia 83, 1160-1168, 2012. doi:10.1016/j.fitote.2012.07.006
32. Zhao PW, Lee DY, Ma ZZ, Huang LS, Sun LP, et al.: The antioxidant effect of carnosol in bovine aortic endothelial cells is mainly mediated via estrogen receptor alpha pathway. Biological and Pharmaceutical Bulletin 35, 1947-1955, 2012.
33. Johnson JJ, Syed DN, Suh Y, Heren CR, Saleem M, et al.: Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res (Phila) 3, 1112-1123, 2010. doi:10.1158/1940-6207.CAPR-10-0168
34. Plouzek CA, Ciolino HP, Clarke R, and Yeh GC: Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer 35, 1541-1545, 1999.
35. Rodrguez-Antona C: Pharmacogenomics of paclitaxel. Pharmacogenomics 11, 621-623, 2010. doi:10.2217/pgs.10.32
36. Sharabani H, Izumchenko E, Wang Q, Kreinin R, Steiner M, et al.: Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int J Cancer 118, 3012-3021, 2006. doi:10.1002/ijc.21736
37. Shabtay A, Sharabani H, Barvish Z, Kafka M, Amichay D, et al.: Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia. Oncology 75, 203-214, 2008. doi:10.1159/000163849
38. Reverchon E and DeMarco I: Supercritical fluid extraction and fractionation of natural matter. The Journal of Supercritical Fluids 38, 146-166, 2006.
39. Pourmortazavi SM and Hajimirsadeghi SS: Supercritical fluid extraction in plant essential and volatile oil analysis. Journal of Chromatography A 1163, 2-24, 2007.
40. Babovic N, Djilas S, Jadranin M, Vajs V, Ivanovic J, et al.: Supercritical carbon dioxide extraction of antioxidant fractions from selected Lamiaceae herbs and their antioxidant capacity. Innovative Food Science & Emerging Technologies 11, 98-107, 2010.
41. Cuvelier M-E, Richard H, and Berset C: Antioxidative activity and phenolic composition of pilot-plant and commercial extracts of sage and rosemary. Journal of the American Oil Chemists' Society 73, 645-652, 1996.
42. Ibanez C, Valdes A, Garca-Canas V, Simo C, Celebier M, et al.: Global Foodomics strategy to investigate the health benefits of dietary constituents. Journal of chromatography A 1248, 139-153, 2012.
43. Baron JA, Cole BF, Mott L, Haile R, Grau M, et al.: Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst 95, 717-722, 2003.
44. Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Jr., Beck GJ, et al.: A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 331, 141-147, 1994. doi:10.1056/NEJM199407213310301
45. Mooney LA, Madsen AM, Tang D, Orjuela MA, Tsai WY, et al.: Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. Cancer Epidemiol Biomarkers Prev 14, 237-242, 2005.
46. Huang MC, Chen HY, Huang HC, Huang J, Liang JT, et al.: C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. Oncogene 25, 3267-3276, 2006. doi:10.1038/sj.onc.1209350
47. Giraldez MD, Lozano JJ, Ramrez G, Hijona E, Bujanda L, et al.: Circulating MicroRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clinical Gastroenterology and Hepatology 11, 681-688, 2012.
48. Johnson JJ: Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett 305, 1-7, 2011. doi:10.1016/j.canlet.2011.02.005
49. Kapoor S: Carnosic acid and its inhibitory effect on tumor growth in systemic malignancies. Oral Dis 19, 427, 2013. doi:10.1111/odi.12055
50. Novotny L, Vachalkova A, and Biggs D: Ursolic acid: an anti-tumorigenic and chemopreventive activity. Minireview. Neoplasma 48, 241-246, 2001.
51. Zimmermann GR, Lehar J, and Keith CT: Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 12, 34-42, 2007. doi:10.1016/j.drudis.2006.11.008
52. European Commission: Directive 2010/67/EU of 20 October 2010 amending Directive 2008/84/EC laying down specific purity criteria on food additives other than colours and sweeteners. Official Journal of the European Union L277, 17-26, 2010.
53. Jordan MJ, Lax V, Rota MC, Loran S, and Sotomayor JA: Relevance of carnosic acid, carnosol, and rosmarinic acid concentrations in the in vitro antioxidant and antimicrobial activities of Rosmarinus officinalis (L.) methanolic extracts. J Agric Food Chem 60, 9603-9608, 2012. doi:10.1021/jf302881t